Strata Critical Medical, Inc.
SRTA
$4.14
-$0.11-2.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 83.54% | 36.70% | 17.05% | 5.42% | -23.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 83.54% | 36.70% | 17.05% | 5.42% | -23.36% |
| Cost of Revenue | 75.68% | 31.97% | 31.15% | 2.30% | -18.44% |
| Gross Profit | 132.75% | 54.69% | -15.36% | 18.14% | -44.35% |
| SG&A Expenses | -9.52% | -16.26% | 966.99% | -3.04% | -23.55% |
| Depreciation & Amortization | 107.00% | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.50% | 16.02% | 67.54% | 0.83% | -21.14% |
| Operating Income | 66.58% | 91.67% | -113.88% | 23.16% | 12.51% |
| Income Before Tax | 27.48% | -71.62% | -224.46% | 18.71% | 78.75% |
| Income Tax Expenses | -- | -- | -- | 79.76% | -- |
| Earnings from Continuing Operations | 27.48% | -71.62% | -235.22% | 17.50% | 78.11% |
| Earnings from Discontinued Operations | -45.79% | 1,726.11% | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.80% | 3,038.38% | 66.95% | 17.50% | 71.15% |
| EBIT | 66.58% | 91.67% | -113.88% | 23.16% | 12.51% |
| EBITDA | 94.19% | 97.20% | -88.72% | 28.86% | 7.63% |
| EPS Basic | 16.36% | 2,885.20% | 68.64% | 21.82% | 72.53% |
| Normalized Basic EPS | 88.47% | 110.07% | -94.95% | 22.75% | 0.10% |
| EPS Diluted | 19.27% | 2,874.00% | 67.74% | 27.17% | 71.54% |
| Normalized Diluted EPS | 88.47% | 110.07% | -94.95% | 22.75% | 0.10% |
| Average Basic Shares Outstanding | 7.84% | 5.65% | 5.09% | 5.40% | 5.04% |
| Average Diluted Shares Outstanding | 7.84% | 5.65% | 5.09% | 5.40% | 5.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |